stella
beta
PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC — Stella
Recruiting
Back to Colorectal Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Chinese PLA General Hospital, Beijing
View full record on ClinicalTrials.gov